(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The xience pro device is currently not commercially available in the us; however, it is similar to a device sold in the us.There was no reported device malfunction and the product was not returned.Dissection is listed in the xience pro everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary stenting procedures.Although a conclusive cause for the reported patient effect and the relationship to the product, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.
|